Stock Market

About Us CEO Letter Real-Time Market Data Co-branding Advertise
    
Symbol:
NASDAQ < $5 Home
> Select Your Market:
OTCBB
NASDAQ $5

  
Untitled Document
   NASDAQ $5 Most Active
  Share Volume
  Dollar Volume
  Transactions
  % Gainers
  % Losers
  $ Gainers
  $ Losers
   Deal Coverage
  Earnings
  Mergers/Aquisitions
  Financings
  Partnerships
  Legal
  Patent Awards
  Dividends
  Stock Splits
  All Categories
   S.E.C Filings
  Annual Reports  (10-K)
  Quarter Reports (10-Q)
  Current Reports (8-K)
  Initial Offerings  (SB-2)
  Dilution Reports (S-8)
  Insiders (Form 3)
  Insiders (Form 4)
  Insiders (Form 5)
  All Categories
   Full Coverage of:
  Foreign Stocks
  American Depos.Rec.
  Delinquents Stocks
  Bankrupt Stocks

Delivered to your email each day at 4 pm, this Institutional-level report covers all critical trading activity for the OTC:BB, Pinksheets and Nasdaq markets.

  

Untitled Document
    
Jul 30
Healthcare Watch: Iridex Lands U.S. Patent For Laser Probe    patent |
Jul 30, 2010 (FinancialWire via COMTEX) --(Comment on this article at http://www.financialwire.net/2010/07/30/iridex-lands-u-s-patent/)July 30, 2010 (FinancialWire) (Go to http://www.financialwire.net/?s=ftrdnwswnd for all of today's featured news.) -- Iridex Corp.    More...
Jul 30
Company '' s Subsidiary LML Patent Corp. Advised Inter-Partes Reexamination Granted    patent |
VANCOUVER, British Columbia, July 30, 2010 (GLOBE NEWSWIRE) -- On July 29, 2010, LML Payment Systems Inc. (the "Corporation") (Nasdaq:LMLP) learned that the United States Patent and Trademark Office had posted a non-final office action on its public Patent Application Information Retrieval ("PAIR") website regarding the inter-partes reexamination    More...
Jul 29
Camtek to Appeal the Decision in Rudolph Patent Infringement Case    patent |
MIGDAL HA'EMEK, Israel, July 29, 2010 /PRNewswire-FirstCall/ -- CamtekLtd. (Nasdaq: CAMT; TASE: CAMT) reported today that the way to appeal is openfollowing the District Court's denial of    More...
Jul 29
Endologix receives FDA approval for PoewrFit aortic extensions    fda approval |
Endologix announced that it has received FDA approval for its new PowerFit Aortic Extensions. The PowerFit extensions are designed to provide physicians with enhanced visibility under fluoroscopy to facilitate precise device placement during completion of the Anatomical Fixation endovascular repair of abdominal aortic aneurysm. ?In addition, PowerFit's independent stent design and 24 circumferential contact points were shown in    More...
Jul 29
Endologix Receives FDA Approval for PowerFit Aortic Extensions    fda approval |
IRVINE, Calif., July 29 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its new PowerFit Aortic Extensions. The    More...
Jul 29
Iridex granted U.S. patent for adjustable laser probe for eye surgery [pre-open]    patent |
Iridex announced the receipt of an Issue Notification from the U.S. Patent and Trademark Office for U.S. Patent No. 7,766,904, "Adjustable Laser Probe For Use In Vitreoretinal Surgery." This patent applies to a number of consumable medical devices already in the product line, collectively identified and sold as Adjustable and Intuitive EndoProbe laser handpieces. The Adjustable Laser Probe speeds up treatments by allowing continuous    More...
Jul 29
IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery    patent |
MOUNTAIN VIEW, Calif., July 29 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the receipt of an Issue Notification from the U.S. Patent and Trademark Office for U.S. Patent No. 7,766,904, "Adjustable Laser Probe For Use In Vitreoretinal Surgery." This    More...
Jul 28
Novavax wins new US patent for influenza VLP vaccines    patent |
Jul 28, 2010 (Datamonitor via COMTEX) --Novavax, a biotechnology company, has received a new US patent for functional influenza virus-like particles.The patent covers the use of influenza gene sequences for high-yield production of consistent influenza virus-like particle (VLP) vaccines to protect against current and future seasonal and pandemic strains of influenza viruses.    More...
Jul 28
WorldHeart wins FDA approval to add 10 sites for Levacor device study    fda approval |
Jul 28, 2010 (Datamonitor via COMTEX) --World Heart Corporation, or WorldHeart, a developer of mechanical circulatory systems, has announced that the FDA has approved the addition of 10 sites to the Levacor ventricular assist device bridge-to-transplant clinical study.WorldHeart's pivotal bridge-to-transplant (BTT) study is now approved to enroll patients at 20 sites in the US.According    More...
Jul 27
Sector Update: Technology Shares Mixed Rambus Wins Patent Spate with Nvidia    patent |
12:30 PM Eastern Daylight Time, 07/27/2010 (MidnightTrader) -- Dow Jones U.S. Technology Index (DJUSTC): +0.7, (+0.12%), to 588.43Top Technology StocksMSFT: -0.1%AAPL: +1.3%IBM: +0.3%CSCO: -0.9%GOOG: +0.2%Technology shares were mixed to higher by mid-day trading as investors sought clear direction.The Dow Jones U.S. Technology Index was up 0.7, or 0.12%,    More...
More Patent Awards news
Jul 27 World Heart gets FDA approval to add clinical sites in Levac...    fda approval |
Jul 27 WorldHeart Receives FDA Approval to Add Clinical Sites in Le...    fda approval |
Jul 27 Novavax Jumps More Than 7% on Issuance of U.S. Patent for In...    patent |
Jul 27 NOVAVAX Announces Issuance of Key U.S. Patent for Influenza ...    patent |
Jul 26 Sector Update: Technology Shares Higher Rambus, Nvidia Paten...    patent |
Jul 26 Investors Await Ruling from U.S. Trade Panel on Whether Nvid...    patents |
Jul 26 Impax Laboratories wins FDA approval for pain drug    fda approval |
Jul 26 SORL Auto Parts was awarded five patents in Q2 of 2010    patents |
Jul 26 SORL Awarded Five Patents in 2010 Second Quarter    second quarter | patents |
Jul 26 New Generation Biofuels files patent for pyrolysis oil based...    patent |
Jul 22 Impax Laboratories Receives Final FDA Approval for Generic O...    fda approval |
Jul 22 Impax Labs Gets FDA Approval for OPANA Generic in 30 mg Tabl...    fda approval |
Jul 22 TeleCommunication Systems Issued Patent    patent |
Jul 22 TeleCommunication Systems issued U.S. patent on secure satel...    patent |
Jul 22 TeleCommunication Systems, Inc. Issued U.S. Patent on Secure...    patent |
Home - About Us - CEO's Letter - Real-Time Market Data - Co-branding - Contact Us - Site map - Stock Market
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither MicrocapMarkets.com nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.


© 2001 - 2010 MicrocapMarkets.com. All rights reserved


Stock Market

Wikipedia describes the stock market as a public market for the trading of company stock and derivatives at an agreed price; these are securities listed on a stock exchange as well as those only traded privately. Now you may be wondering how I can start investing in the stock market and that?s easy come in our stock message boards and discuss with traders which stock market broker would be the best for you. We know the stock market is difficult alone so come talk about stocks you were following or already invested in.

Stock Message Boards

Our stock message boards are here to help all traders by having a board to communicate and discuss stock market research to help other traders make money. Stock market research is key to being profitable in the stock market. Our stock message boards also have the ability to create your own stock market trading group and invite your friends to follow. If you have feedback on our stock message boards feel free to contact us we are here to make this the best for our members.